137 related articles for article (PubMed ID: 24080480)
1. Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells.
Alessio M; Zanellato I; Bonarrigo I; Gabano E; Ravera M; Osella D
J Inorg Biochem; 2013 Dec; 129():52-7. PubMed ID: 24080480
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin.
Ravera M; Gabano E; Zanellato I; Bonarrigo I; Escribano E; Moreno V; Font-Bardia M; Calvet T; Osella D
Dalton Trans; 2012 Mar; 41(11):3313-20. PubMed ID: 22286213
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of platinum-ethacrynic acid conjugates in the treatment of mesothelioma.
Zanellato I; Bonarrigo I; Sardi M; Alessio M; Gabano E; Ravera M; Osella D
ChemMedChem; 2011 Dec; 6(12):2287-93. PubMed ID: 22025407
[TBL] [Abstract][Full Text] [Related]
4. An unsymmetric cisplatin-based Pt(iv) derivative containing 2-(2-propynyl)octanoate: a very efficient multi-action antitumor prodrug candidate.
Gabano E; Ravera M; Zanellato I; Tinello S; Gallina A; Rangone B; Gandin V; Marzano C; Bottone MG; Osella D
Dalton Trans; 2017 Oct; 46(41):14174-14185. PubMed ID: 28984330
[TBL] [Abstract][Full Text] [Related]
5. Bis- and Tetrakis(carboxylato)platinum(IV) complexes with mixed axial ligands - synthesis, characterization, and cytotoxicity.
Hoffmeister BR; Hejl M; Adib-Razavi MS; Jakupec MA; Galanski M; Keppler BK
Chem Biodivers; 2015 Apr; 12(4):559-74. PubMed ID: 25879501
[TBL] [Abstract][Full Text] [Related]
6. Novel trans-platinum complexes of the histone deacetylase inhibitor valproic acid; synthesis, in vitro cytotoxicity and mutagenicity.
Griffith DM; Duff B; Suponitsky KY; Kavanagh K; Morgan MP; Egan D; Marmion CJ
J Inorg Biochem; 2011 Jun; 105(6):793-9. PubMed ID: 21497577
[TBL] [Abstract][Full Text] [Related]
7. New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells.
Novohradsky V; Zerzankova L; Stepankova J; Vrana O; Raveendran R; Gibson D; Kasparkova J; Brabec V
Biochem Pharmacol; 2015 Jun; 95(3):133-44. PubMed ID: 25888926
[TBL] [Abstract][Full Text] [Related]
8. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
[TBL] [Abstract][Full Text] [Related]
9. Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands.
Novohradsky V; Zerzankova L; Stepankova J; Vrana O; Raveendran R; Gibson D; Kasparkova J; Brabec V
J Inorg Biochem; 2014 Nov; 140():72-9. PubMed ID: 25063910
[TBL] [Abstract][Full Text] [Related]
10. Platinum-bisphosphonate complexes have proven to be inactive chemotherapeutics targeted for malignant mesothelioma because of inappropriate hydrolysis.
Margiotta N; Ostuni R; Piccinonna S; Natile G; Zanellato I; Boidi CD; Bonarrigo I; Osella D
J Inorg Biochem; 2011 Apr; 105(4):548-57. PubMed ID: 21334282
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo therapeutic efficacy of the PPAR-γ agonist troglitazone in combination with cisplatin against malignant pleural mesothelioma cell growth.
Hamaguchi N; Hamada H; Miyoshi S; Irifune K; Ito R; Miyazaki T; Higaki J
Cancer Sci; 2010 Sep; 101(9):1955-64. PubMed ID: 20608936
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
[TBL] [Abstract][Full Text] [Related]
13. Valuable insight into the anticancer activity of the platinum-histone deacetylase inhibitor conjugate, cis-[Pt(NH3)2malSAHA-2H)].
Brabec V; Griffith DM; Kisova A; Kostrhunova H; Zerzankova L; Marmion CJ; Kasparkova J
Mol Pharm; 2012 Jul; 9(7):1990-9. PubMed ID: 22591133
[TBL] [Abstract][Full Text] [Related]
14. Studies on the photoactivation of two cytotoxic trans,trans,trans-diazidodiaminodihydroxo-Pt(IV) complexes.
Westendorf AF; Bodtke A; Bednarski PJ
Dalton Trans; 2011 May; 40(19):5342-51. PubMed ID: 21461431
[TBL] [Abstract][Full Text] [Related]
15. Combined treatment with cisplatin and sirolimus to enhance cell death in human mesothelioma.
Hartman ML; Esposito JM; Yeap BY; Sugarbaker DJ
J Thorac Cardiovasc Surg; 2010 May; 139(5):1233-40. PubMed ID: 19853261
[TBL] [Abstract][Full Text] [Related]
16. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
Siddik ZH; al-Baker S; Thai G; Khokhar AR
Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
[TBL] [Abstract][Full Text] [Related]
17. Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: how long the organic chain should be?
Zanellato I; Bonarrigo I; Colangelo D; Gabano E; Ravera M; Alessio M; Osella D
J Inorg Biochem; 2014 Nov; 140():219-27. PubMed ID: 25171667
[TBL] [Abstract][Full Text] [Related]
18. Influence of equatorial and axial carboxylato ligands on the kinetic inertness of platinum(IV) complexes in the presence of ascorbate and cysteine and within DLD-1 cancer cells.
Chen CK; Zhang JZ; Aitken JB; Hambley TW
J Med Chem; 2013 Nov; 56(21):8757-64. PubMed ID: 24107138
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic and antitumor effects of platinum(IV)-octanoato conjugates.
Novohradsky V; Zanellato I; Marzano C; Pracharova J; Kasparkova J; Gibson D; Gandin V; Osella D; Brabec V
Sci Rep; 2017 Jun; 7(1):3751. PubMed ID: 28623355
[TBL] [Abstract][Full Text] [Related]
20. Effect of citrate on malignant pleural mesothelioma cells: a synergistic effect with cisplatin.
Zhang X; Varin E; Allouche S; Lu Y; Poulain L; Icard P
Anticancer Res; 2009 Apr; 29(4):1249-54. PubMed ID: 19414371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
